Skip to main content

Seeing and Measuring Hepatobiliary Disease Using Artificial Intelligence, Presented by Perspectum at RSNA 2019

Perspectum will be showcasing the application of Artificial Intelligence in their FDA-cleared, quantitative imaging services — LiverMultiScan for liver tissue characterization and MRCP+ for biliary tree visualization — at RSNA’s annual meeting this year.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191114005604/en/

Example MRCP+ Images (Graphic: Business Wire)

Example MRCP+ Images (Graphic: Business Wire)

Perspectum’s co-founder, Professor Sir Michael Brady, will show how machine learning can be integrated with LiverMultiScan and MRCP+ to enhance disease detection with improved precision, and potentially monitor disease progression. A total of four abstracts highlighting the utility of Perspectum’s technology will be presented at RSNA.

Details of the presentations are listed below:

Oral presentations

  • A Machine Learning Pipeline for Automatic Multi-Site-Vendor Quantitative MRI Analysis of the Liver | SSE09-01 | Monday, 3:00 PM – 4:00 PM | Room N230B
  • Quantitative Biliary Tree Imaging by MRI: A Novel Method of Assessing Change Over Time in Hepatobiliary Disease via MRCP | SSG14-03 | Tuesday, 10:30 AM – 12:00 PM | Room S504AB
  • Diagnosis of Pediatric Liver Diseases with Multiparametric MRI and Quantitative Magnetic Resonance Cholangiopancreatography (MRCP) Analysis | RC413-02 | Tuesday, 3:00 PM – 6:00 PM | Room E353B

Poster presentation

  • Assessing the Accuracy, Reproducibility and Repeatability of Novel Quantitative Approach to MRCP Imaging | IN005-EB-SUB | Sunday 1:00 PM – 1:30 PM | Learning Center

Quantitative biliary tree imaging with MRCP+ reveals differences between AIH and PSC patients (images above). PSC patients show a significant increase in biliary tree strictures and dilatations between baseline and 1-year follow up, which is not observed in AIH patients.

"Monitoring progression of this unpredictable disease remains a major challenge for clinicians managing PSC patients. By objectively quantifying changes in the bile ducts, MRCP+ yields additional information to conventional MRCP. PSC Support is encouraged by this technology and we hope that it can help to reduce uncertainty for patients." – Martine Walmsley, PSC Support

Visit Perspectum at booth #10112 in the AI showcase to find out more. To reserve a meeting or connect with the team, visit www.perspectum.com/contact

Contacts:

Jasmin Hounsell 
Jasmin.Hounsell@perspectum.com

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.